Your Commercial Data Stack Has No Shared Language: How to Build a Unified Data Model for Life Sciences GTM
Here is a pattern that shows up repeatedly in growth-stage life sciences companies: the commercial team runs Salesforce, marketing runs HubSpot or Marketo, and someone in IT stood up a Snowflake instance six months ago to “centralize everything.” Two years later, there are three different definitions of “account,” five ways to count a “contact,” and nobody agrees on what an “active opportunity” means. Every downstream report pulls from a different source, and the AI initiative your VP of Commercial just greenlit is about to inherit all of it.
This is not a data quality problem. It is a semantic problem. And the fix is not another ETL pipeline.
The Actual Problem: Fragmentation by Layer
Growth-stage life sciences companies build their commercial stack in layers, not in systems. The CRM goes in first, usually Salesforce, configured by whoever owned sales ops at the time. The MAP comes next, wired to Salesforce through a standard connector that syncs leads and contacts but drops most of the context. Then comes the data warehouse, built to answer a specific reporting question, often pipeline by region or MQL volume. Each layer made sense when it was added. Together, they produce a stack where the same entity, say a health system account, exists in four places with four different identifiers, four different field definitions, and zero shared logic for how to roll up contacts, activities, or revenue to that account.
The consequence shows up in predictable ways. Your sales forecast uses Salesforce opportunity data. Your marketing attribution model uses MAP engagement data processed in Snowflake. Your field team’s territory report uses a CSV that someone refreshes weekly. When leadership asks a simple question like “which accounts are engaging but have no open opportunity,” no one can answer it without a two-day data pull because there is no single place where “engaging” and “open opportunity” share a definition.
What a Unified Commercial Data Model Actually Means
A unified commercial data model is not a single database. It is a shared semantic layer: a set of agreed-upon definitions, grain levels, and relationships that every downstream consumer, whether a BI dashboard, a forecast model, or an AI agent, reads from the same source of truth.
Building one for a life sciences GTM stack requires three design decisions made in the right order.
First, define your entities and their canonical identifiers. In life sciences, the core entities are accounts (health systems, IDNs, physician groups, hospitals), contacts (HCPs, influencers, economic buyers), and interactions (calls, emails, meetings, samples, events). Before you touch dbt or Snowflake, agree on what makes an account unique. Is it a Salesforce Account ID? An NPI for a physician practice? A CMS certification number for a hospital? Pick one canonical key per entity type and enforce it upstream. Every other identifier becomes an alias. This sounds obvious. Almost no one has done it before they start building pipelines.
Second, design your grain before you design your tables. The most common analytics engineering mistake in pharma commercial data is building a single “account activity” table that mixes call logs, email opens, sample records, and meeting notes at different timestamps without a clear grain declaration. When an AI agent or a forecasting model reads that table, it cannot distinguish a lightweight digital touchpoint from a high-value field visit without hard-coded logic scattered across fifteen downstream models. Define your grain per domain: one row per account-day for engagement scoring, one row per opportunity-stage-date for pipeline history, one row per HCP-product-quarter for call activity. Separate tables, clear grain, consistent keys.
Third, build your semantic definitions in a transformation layer, not in your BI tool. dbt is the right place for this in a Snowflake environment. Define what “active account” means once, in a dbt model, as a documented, tested, version-controlled SQL expression. Define what “engaged contact” means once. Define your opportunity stages, your coverage thresholds, your territory roll-up logic. Once those definitions live in dbt, every dashboard, every report, and every AI prompt that queries Snowflake draws from the same logic. When the definition changes, you change it in one place, run your tests, and deploy. You do not chase down fourteen reports built by fourteen different analysts who each hard-coded their own version.
Life Sciences Makes This Harder, and More Important
Life sciences commercial teams operate under constraints that make data fragmentation especially costly. HCP engagement data carries compliance obligations under the Open Payments framework and, depending on market, under GDPR or CCPA. Promotional materials and sample activity touch FDA promotional regulations. Territory alignment changes happen frequently as companies launch new indications or adjust field force size. All of this means that a fragmented data model is not just an analytics inconvenience. It is a compliance risk. If your sample activity data and your HCP contact records use different identifiers and live in disconnected tables, your ability to produce a clean aggregate spend report or an accurate call plan is structurally compromised.
Growth-stage companies also face a resource constraint that makes this feel daunting: you likely have one or two analytics engineers, a RevOps manager, and a sales ops person who also runs Salesforce admins. You cannot boil the ocean. The right approach is to start with the entities and domains that feed your highest-priority use case, whether that is pipeline forecasting, territory coverage reporting, or an AI copilot for your field team, and build the semantic layer for that scope first. A well-designed model for three entities is worth more than a sprawling schema that nobody trusts.
Building the Foundation Before the AI Initiatives Arrive
If your company is planning to deploy AI agents for call planning, next-best-action recommendations, or forecast summaries, the quality of your commercial data model is the single largest factor in whether those agents work. Language models do not fix semantic inconsistency. They amplify it. An agent that queries a fragmented schema will produce confident-sounding answers built on bad logic, which is worse than no answer at all.
The companies that get real value from AI in their commercial operations are the ones that did the infrastructure work first: canonical entity definitions, clean grain, transformation logic that lives in one tested layer, and a Salesforce-to-Snowflake pipeline that preserves context rather than flattening it. That work is not glamorous. It does not ship in a press release. But it is the reason some teams can build an AI-assisted territory review in two weeks while others are still arguing about which account list to use.
If you are building or rebuilding your commercial data model and want a second opinion on the design, or if you are trying to figure out where to start before your next AI initiative lands on your roadmap, Vida Solutions works directly with life sciences data and RevOps teams on exactly this problem. The conversation is worth having before the pipelines are in production.
